Valtrex (Valaciclovir)
What is Valtrex?
Valtrex is
a new high-performance product for the treatment of herpes; it is a
second-generation antiviral product that came to replace acyclovir and its
analogues. The active ingredient is valaciclovir. Valaciclovir accumulates only
in those cells where the virus multiplies. Passing complex chain of chemical
reactions inside the cell, valaciclovir is embedded inthe virus and irreversibly
blocks its reduplication. The medicine is produced in form of tablets for oral
administration.
Drug Description
Valtrex is a potential new generation antiviral medicine administered for peroral
use. Valtrex is applied for the treatment of skin diseases of the mucous
membranes caused by the virus Herpes simplex (including genital herpes) and as
relapse prevention for diseases caused by the virus Herpes simplex. Valtrex is
also used to prevent CMV infection and disease developing after organ
transplantation.
How to Use It?
Dose and duration of treatment depend on the type and extent of the disease and
response to the therapy of every individual patient. Valtrex is administered in
the form of tablet for the treatment of herpes zoster by 1g 3 times daily for 7
days; for the treatment of Herpes simplex - 500mg 2 times a day. In recurrent
disease caused by the virus Herpes simplex, treatment begins immediately after
the onset of symptoms within 5 days. If necessary, the first phase of treatment
duration is increased to 10 days. More details are provided in the
manufacturer's instructions.
Safety Precautions
Persons with hypersensitivity, bone marrow transplantation, symptomatic HIV infection, a kidney transplant, liver/kidney failure, pregnancy, and lactation should restrain from its therapy. Valtrex should not be used in infants.